Arie Perry, M.D
Arie Perry is a Professor at the University of California in San Francisco, where he serves as the Director of the Neuropathology Division and the Neuropathology Fellowship program. He received his MD and residency training at UT Southwestern Medical Center in Dallas, Texas, followed by fellowships in surgical pathology, neuropathology, and molecular cytogenetics research at the Mayo Clinic in Rochester, MN, where he worked closely with his mentor, the late Dr. Bernd Scheithauer. His interests have focused mostly on classification, grading, and molecular characterization of both adult and pediatric brain tumors. He has authored over 460 publications and participated as a senior advisor/editor in the WHO 2016 brain tumor classification update. He has also served as the chief editor for Brain Pathology (official journal for the International Society of Neuropathology), the Practical Surgical Neuropathology textbook (2010 and 2018 editions), and the 9th edition of Greenfield’s Neuropathology (2015). Dr. Perry maintains an active surgical neuropathology consult service and is a frequently invited lecturer. In addition, he enjoys creative modes of teaching making use of his longstanding passion for music. In this respect, he has been featured in several media stories for using "neuropathology songs" in education, including a CD recording of 16 medical ballads and a recent YouTube male a cappella rendition of ‘Brain Tumor Rhapsody’ set to Bohemian Rhapsody.
Ian Olver AM
Ian Olver is a medical oncologist, bioethicist and researcher. He is currently Professor of Translational Cancer Research, and Director, University of South Australia Cancer Research Institute where he heads a psycho-oncology research team. He is immediate past President of the Multinational Association of Supportive Care in Cancer and Chaired the Australian Health Ethics Committee of the NHMRC for the past 6 years. He has published over 300 journal papers, 22 book chapters 4 books and edited 4 books. In 2008 he was awarded the Cancer Achievement Award by the Medical Oncology Group of Australia and in 2014 the Gold Medal of Cancer Council Australia for distinguished service in cancer. He was awarded Membership of the Order of Australia (AM) in 2011 “For service to medical oncology as a clinician, researcher, administrator and mentor, and to the community through leadership roles with cancer control organisations.”
Dr Lauren Thurgood
Lauren completed her PhD in 2011 at Flinders University in the area of kidney disease and carried out her postdoctoral studies in B-cell autoimmunity. Her interest in B-cell biology and skills and knowledge of proteomic techniques saw her take up a position in haematology, where she began to unravel the proteome of leukaemia cells. She also developed a strong interest in the role of secreted proteins in tumour microenvironment and how these can promote survival of lymphocytes from patients with chronic lymphocytic leukaemia (CLL). More recently, her work has focused on cancer cell metabolism and understanding the fuel requirements that promote proliferation of CLL cells within the lymph nodes and bone marrow, with the view to disrupting these pathways with new therapies. She has extensive experience in identification of proteins from archived tissue samples.
She was recently awarded a 3-year early career researcher fellowship by Cancer Council SA (Beat Cancer Scheme) to continue carrying out her work investigating cancer cell bioenergetics. She currently works in Molecular Medicine and Pathology and is part of the CLL Research Team, headed by Associate Professor Bryone Kuss.
more speakers to be listed…